| |   | | | | By Bob Herman and Tara Bannow Michael M. Santiago/Getty Images Next year, United will offer employer health plans that have no copays or out-of-pocket costs for five vital drugs, including insulin. Read More | | By Nicholas Florko Allen G. Breed/AP The main manufacturer of the abortion pill mifepristone hired its own team of lobbyists for the first time this summer. Read More | | By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. Read More | | Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis — at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. | | By Jay K. Varma and Joseph Osmundson Karen Ducey/Getty Images Tecovirimat (TOPXX), an FDA-approved drug, can be used to treat monkeypox. But it's almost impossible for people with the disease to get it. Read More | | By Tara Bannow RHONA WISE/AFP via Getty Images Parents are suing insurers to get them to cover wilderness therapy, an industry that's itself trying to recover from a sordid past. Read More | |
No comments